Table 6.
The top 10 co-cited references with the strongest burst on cancer gene therapy.
| No. | Title | Strength | Journal | First author | Year |
|---|---|---|---|---|---|
| 1 | Cancer statistics, 2014 | 10.81 | Ca-Cancer J Clin | Siegel R | 2014 |
| 2 | Knocking down barriers: advances in siRNA delivery | 10.68 | Nat Rev Drug Discov | Whitehead KA | 2009 |
| 3 | Nonviral vectors for gene delivery | 10.68 | Chem Rev | Mintzer MA | 2009 |
| 4 | Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen | 10.68 | Blood | Johnson LA | 2009 |
| 5 | B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells | 8.98 | Blood | Kochenderfer JN | 2012 |
| 6 | Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia | 8.41 | Nature | Cavazzana-Calvo M | 2010 |
| 7 | Cancer statistics, 2013 | 8.13 | Ca-Cancer J Clin | Siegel R | 2013 |
| 8 | Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles | 8.13 | Nature | Davis ME | 2010 |
| 9 | Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy | 7.28 | Science | Cartier N | 2009 |
| 10 | Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer | 7 | Nat Med | Heo J | 2013 |